financetom
Business
financetom
/
Business
/
Nordson Fiscal Q3 Adjusted Earnings Decline, Sales Rise; Full-Year Guidance Updated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nordson Fiscal Q3 Adjusted Earnings Decline, Sales Rise; Full-Year Guidance Updated
Aug 22, 2024 6:41 PM

05:07 PM EDT, 08/21/2024 (MT Newswires) -- Nordson ( NDSN ) reported fiscal Q3 adjusted earnings late Wednesday of $2.41 per diluted share, down from $2.55 a year earlier.

Analysts polled by Capital IQ expected $2.34.

Sales for the quarter ended July 31 were $661.6 million, compared with $648.7 million a year earlier. Analysts surveyed by Capital IQ expected $656.6 million.

For fiscal 2024, the company said it now expects adjusted EPS of $9.45 to $9.65 on revenue of $2.67 billion to $2.71 billion. It previously projected adjusted EPS of $9.35 to $9.75 on revenue growth of flat to 2%.

Analysts expect EPS of $9.47 on revenue of $2.67 billion.

Price: 248.70, Change: +0.92, Percent Change: +0.37

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Singapore's UOB looking at North Asia opportunities as wealth earnings jump
Singapore's UOB looking at North Asia opportunities as wealth earnings jump
Jul 31, 2024
By Yantoultra Ngui SINGAPORE (Reuters) -Singapore's United Overseas Bank (UOB) reported a 40% surge in wealth management income during the second quarter and said it was looking at opportunities in North Asia such as in China and Hong Kong to bolster the business. Like other Singaporean banks, UOB has benefited from strong inflows of wealth into Asia due to the...
Japan's Otsuka Pharma to pay up to $1.1 bln to acquire Jnana Therapeutics
Japan's Otsuka Pharma to pay up to $1.1 bln to acquire Jnana Therapeutics
Jul 31, 2024
TOKYO, Aug 1 (Reuters) - Japan's Otsuka Pharmaceutical said on Thursday it would pay more than $1 billion to acquire U.S.-based Jnana Therapeutics as it looks to expand its drug pipeline. Otsuka will pay $800 million to Jnana shareholders along with up to $325 million in development and regulatory milestones, the Japanese company said in a statement. The deal is...
Toyota posts 17% rise in Q1 operating profit, in line with expectations
Toyota posts 17% rise in Q1 operating profit, in line with expectations
Jul 31, 2024
TOKYO (Reuters) - Toyota Motor ( TM ) said on Thursday it posted a 17% rise in first-quarter operating profit, as the Japanese automaker got a boost from cost reduction efforts and the weak yen that helped offset lower sales and production volume in Japan. The world's top-selling automaker said operating profit for the three months through June totalled 1.3...
BRIEF-Otsuka Holdings Co Ltd - Otsuka Pharmaceutical To Acquire Jnana Therapeutics
BRIEF-Otsuka Holdings Co Ltd - Otsuka Pharmaceutical To Acquire Jnana Therapeutics
Jul 31, 2024
Aug 1 (Reuters) - Otsuka Holdings Co Ltd ( OTSKY ): * OTSUKA HOLDINGS CO LTD ( OTSKY ) - OTSUKA PHARMACEUTICAL TO ACQUIRE JNANA THERAPEUTICS * OTSUKA HOLDINGS CO LTD ( OTSKY ) - OTSUKA WILL PAY USD $800 MILLION TO THE SHAREHOLDERS OF JNANA UPON COMPLETION OF THE ACQUISITION, AS WELL AS UP TO AN ADDITIONAL USD $325...
Copyright 2023-2026 - www.financetom.com All Rights Reserved